Camron D. Bryant - Publications

Affiliations: 
Pharmacology Boston University School of Medicine, Boston, MA 
Area:
qtl mapping of addictive traits

43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Borrelli KN, Wingfield KK, Yao EJ, Zamorano CA, Sena KD, Beierle JA, Roos MA, Zhang H, Wachman EM, Bryant CD. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice. Neuropharmacology. 240: 109732. PMID 37774943 DOI: 10.1016/j.neuropharm.2023.109732  0.349
2023 Borrelli KN, Wingfield KK, Yao EJ, Zamorano CA, Sena KD, Beierle JA, Roos MA, Zhang H, Wachman EM, Bryant CD. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice. Biorxiv : the Preprint Server For Biology. PMID 37609129 DOI: 10.1101/2023.08.04.552033  0.349
2023 Parisien M, van Reij RRI, Khoury S, Koseli E, Karaky M, van den Hoogen NJ, Peng G, Allegri M, de Gregori M, Chelly JE, Rakel BA, Aasvang EK, Kehlet H, Buhre WFFA, Bryant CD, et al. Genome-wide association study suggests a critical contribution of the adaptive immune system to chronic post-surgical pain. Medrxiv : the Preprint Server For Health Sciences. PMID 36945481 DOI: 10.1101/2023.01.24.23284520  0.463
2022 Ray MH, Williams BR, Kuppe MK, Bryant CD, Logan RW. A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder. Frontiers in Integrative Neuroscience. 16: 899637. PMID 35757099 DOI: 10.3389/fnint.2022.899637  0.342
2022 Beierle JA, Yao EJ, Goldstein SI, Lynch WB, Scotellaro JL, Shah AA, Sena KD, Wong AL, Linnertz CL, Averin O, Moody DE, Reilly CA, Peltz G, Emili A, Ferris MT, ... Bryant CD, et al. Zhx2 is a candidate gene underlying oxymorphone metabolite brain concentration associated with state-dependent oxycodone reward. The Journal of Pharmacology and Experimental Therapeutics. PMID 35688478 DOI: 10.1124/jpet.122.001217  0.364
2021 Goldberg LR, Yao EJ, Kelliher JC, Reed ER, Wu Cox J, Parks C, Kirkpatrick SL, Beierle JA, Chen MM, Johnson WE, Homanics GE, Williams RW, Bryant CD, Mulligan MK. A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity. Genes, Brain, and Behavior. e12774. PMID 34677900 DOI: 10.1111/gbb.12774  0.321
2021 Borrelli KN, Yao EJ, Yen WW, Phadke RA, Ruan QT, Chen MM, Kelliher JC, Langan CR, Scotellaro JL, Babbs RK, Beierle JC, Logan RW, Johnson WE, Wachman EM, Cruz-Martín A, ... Bryant CD, et al. Sex differences in behavioral and brainstem transcriptomic neuroadaptations following neonatal opioid exposure in outbred mice. Eneuro. PMID 34479978 DOI: 10.1523/ENEURO.0143-21.2021  0.407
2020 Bryant CD, Healy AF, Ruan QT, Coehlo MA, Lustig E, Yazdani N, Luttik KP, Tran T, Swancy I, Brewin LW, Chen MM, Szumlinski KK. Sex-dependent effects of an Hnrnph1 mutation on fentanyl addiction-relevant behaviors but not antinociception in mice. Genes, Brain, and Behavior. e12711. PMID 33145940 DOI: 10.1111/gbb.12711  0.478
2020 Ulker E, Caillaud M, Patel T, White A, Rashid D, Alqasem M, Lichtman AH, Bryant CD, Damaj MI. C57BL/6 Substrain Differences in Formalin-Induced Pain-Like Behavioral Responses. Behavioural Brain Research. 112698. PMID 32428630 DOI: 10.1016/J.Bbr.2020.112698  0.544
2020 Ruan QT, Yazdani N, Reed ER, Beierle JA, Peterson LP, Luttik KP, Szumlinski KK, Johnson WE, Ash PEA, Wolozin B, Bryant CD. 5' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 32401417 DOI: 10.1096/Fj.202000092R  0.415
2020 Babbs RK, Beierle JA, Yao EJ, Kelliher JC, Medeiros AR, Anandakumar J, Shah AA, Chen MM, Johnson WE, Bryant CD. The effect of the demyelinating agent cuprizone on binge-like eating of sweetened palatable food in female and male C57BL/6 substrains. Appetite. 104678. PMID 32209386 DOI: 10.1016/j.appet.2020.104678  0.409
2020 Brown CN, Fultz EK, Ferdousian S, Rogers S, Lustig E, Page A, Shahin JR, Flaherty DM, Von Jonquieres G, Bryant CD, Kippin TE, Szumlinski KK. Transgenic Analyses of Homer2 Function Within Nucleus Accumbens Subregions in the Regulation of Methamphetamine Reward and Reinforcement in Mice. Frontiers in Psychiatry. 11: 11. PMID 32116834 DOI: 10.3389/fpsyt.2020.00011  0.447
2020 Sern KR, Fultz EK, Coelho MA, Bryant CD, Szumlinski KK. A prior history of binge-drinking increases sensitivity to the motivational valence of methamphetamine in female C57BL/6J mice. Substance Abuse : Research and Treatment. 14: 1178221819897073. PMID 32009790 DOI: 10.1177/1178221819897073  0.345
2019 Ruan QT, Yazdani N, Blum BC, Beierle JA, Lin W, Coelho MA, Fultz EK, Healy AF, Shahin JR, Kandola AK, Luttik KP, Zheng K, Smith NJ, Cheung J, Mortazavi F, ... ... Bryant CD, et al. A mutation in that decreases methamphetamine-induced reinforcement, reward, and dopamine release and increases synaptosomal hnRNP H and mitochondrial proteins. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 31704785 DOI: 10.1523/Jneurosci.1808-19.2019  0.365
2019 Babbs RK, Beierle JA, Ruan QT, Kelliher JC, Chen MM, Feng AX, Kirkpatrick SL, Benitez FA, Rodriguez FA, Pierre JJ, Anandakumar J, Kumar V, Mulligan MK, Bryant CD. Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Genetic Background, Parent-of Origin, and Sex. G3 (Bethesda, Md.). PMID 31324746 DOI: 10.1534/G3.119.400470  0.398
2019 Mulligan MK, Abreo T, Neuner SM, Parks C, Watkins CE, Houseal MT, Shapaker TM, Hook M, Tan H, Wang X, Ingels J, Peng J, Lu L, Kaczorowski CC, Bryant CD, et al. Identification of a Functional Non-coding Variant in the GABA Receptor α2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience Research. Frontiers in Genetics. 10: 188. PMID 30984232 DOI: 10.3389/Fgene.2019.00188  0.367
2019 Bryant CD, Bagdas D, Goldberg LR, Khalefa T, Reed ER, Kirkpatrick SL, Kelliiher JC, Chen MM, Johnson WE, Mulligan MK, Damaj MI. C57BL/6 substrain differences in inflammatory and neuropathic nociception and genetic mapping of a major quantitative trait locus underlying acute thermal nociception. Molecular Pain. 1744806918825046. PMID 30632432 DOI: 10.1177/1744806918825046  0.4
2018 Babbs RK, Kelliher JC, Scotellaro JL, Luttik KP, Mulligan MK, Bryant CD. Genetic differences in the behavioral organization of binge eating, conditioned food reward, and compulsive-like eating in C57BL/6J and DBA/2J strains. Physiology & Behavior. PMID 30261172 DOI: 10.1016/J.Physbeh.2018.09.013  0.417
2018 Ruan QT, Yazdani N, Beierle JA, Hixson KM, Hokenson KE, Apicco DJ, Luttik KP, Zheng K, Maziuk BF, Ash PEA, Szumlinski KK, Russek SJ, Wolozin B, Bryant CD. Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation. Neuroscience Letters. PMID 30003938 DOI: 10.1016/J.Neulet.2018.07.015  0.317
2018 Apicco DJ, Ash PEA, Maziuk B, LeBlang C, Medalla M, Al Abdullatif A, Ferragud A, Botelho E, Ballance HI, Dhawan U, Boudeau S, Cruz AL, Kashy D, Wong A, Goldberg LR, ... ... Bryant CD, et al. Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo. Nature Neuroscience. 21: 72-80. PMID 29273772 DOI: 10.1038/S41593-017-0022-Z  0.315
2017 Goldberg LR, Kirkpatrick SL, Yazdani N, Luttik KP, Lacki OA, Babbs RK, Jenkins DF, Johnson WE, Bryant CD. Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating. Genes, Brain, and Behavior. PMID 28594147 DOI: 10.1111/Gbb.12397  0.572
2016 Young EE, Bryant CD, Lee SE, Peng X, Cook B, Nair HK, Dreher KJ, Zhang X, Palmer AA, Chung JM, Mogil JS, Chesler EJ, Lariviere WR. Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. Genes, Brain, and Behavior. PMID 27231153 DOI: 10.1111/Gbb.12302  0.589
2016 Yazdani N, Shen Y, Johnson WE, Bryant CD. Striatal transcriptome analysis of a congenic mouse line (chromosome 11: 50-60Mb) exhibiting reduced methamphetamine sensitivity. Genomics Data. 8: 77-80. PMID 27222804 DOI: 10.1016/j.gdata.2016.03.009  0.361
2015 Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD. Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity. Plos Genetics. 11: e1005713. PMID 26658939 DOI: 10.1371/Journal.Pgen.1005713  0.617
2014 Kirkpatrick SL, Bryant CD. Behavioral architecture of opioid reward and aversion in C57BL/6 substrains. Frontiers in Behavioral Neuroscience. 8: 450. PMID 25628547 DOI: 10.3389/fnbeh.2014.00450  0.527
2014 Zhou L, Bryant CD, Loudon A, Palmer AA, Vitaterna MH, Turek FW. The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice. Sleep. 37: 785-93, 793A-793C. PMID 24744456 DOI: 10.5665/Sleep.3590  0.501
2014 Bryant CD, Guido MA, Kole LA, Cheng R. The heritability of oxycodone reward and concomitant phenotypes in a LG/J × SM/J mouse advanced intercross line. Addiction Biology. 19: 552-61. PMID 23231598 DOI: 10.1111/Adb.12016  0.542
2012 Bryant CD, Kole LA, Guido MA, Cheng R, Palmer AA. Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line. Frontiers in Genetics. 3: 126. PMID 22798962 DOI: 10.3389/Fgene.2012.00126  0.634
2012 Bryant CD, Kole LA, Guido MA, Sokoloff G, Palmer AA. Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis. Genes, Brain, and Behavior. 11: 623-32. PMID 22487465 DOI: 10.1111/J.1601-183X.2012.00795.X  0.614
2012 Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA. Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1026-35. PMID 22089318 DOI: 10.1038/Npp.2011.287  0.693
2011 Bryant CD. The blessings and curses of C57BL/6 substrains in mouse genetic studies. Annals of the New York Academy of Sciences. 1245: 31-3. PMID 22211972 DOI: 10.1111/j.1749-6632.2011.06325.x  0.322
2009 Hofford RS, Hodgson SR, Roberts KW, Bryant CD, Evans CJ, Eitan S. Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal. Behavioural Pharmacology. 20: 576-83. PMID 19738463 DOI: 10.1097/Fbp.0B013E32832Ec57E  0.756
2009 Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA. A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes, Brain, and Behavior. 8: 795-805. PMID 19694818 DOI: 10.1111/J.1601-183X.2009.00525.X  0.687
2009 Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS. Pavlovian conditioning of multiple opioid-like responses in mice. Drug and Alcohol Dependence. 103: 74-83. PMID 19419821 DOI: 10.1016/J.Drugalcdep.2009.03.016  0.721
2009 Bryant CD, Graham ME, Distler MG, Munoz MB, Li D, Vezina P, Sokoloff G, Palmer AA. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology. 203: 703-11. PMID 19050854 DOI: 10.1007/S00213-008-1417-Z  0.752
2008 Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA. Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. Journal of Neurogenetics. 22: 315-31. PMID 19085272 DOI: 10.1080/01677060802357388  0.694
2008 Gioiosa L, Chen X, Watkins R, Klanfer N, Bryant CD, Evans CJ, Arnold AP. Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice. Hormones and Behavior. 53: 124-30. PMID 17956759 DOI: 10.1016/J.Yhbeh.2007.09.003  0.642
2006 Bryant CD, Roberts KW, Byun JS, Fanselow MS, Evans CJ. Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice. Pharmacology, Biochemistry, and Behavior. 85: 769-79. PMID 17196637 DOI: 10.1016/J.Pbb.2006.11.012  0.719
2006 Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 291: R315-26. PMID 16601258 DOI: 10.1152/Ajpregu.00831.2005  0.764
2005 Bryant CD, Zaki PA, Carroll FI, Evans CJ. Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes Clinical Neuroscience Research. 5: 103-115. DOI: 10.1016/J.Cnr.2005.08.006  0.759
2003 Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 10331-7. PMID 14614092 DOI: 10.1523/Jneurosci.23-32-10331.2003  0.746
2003 Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D, Polakiewicz R, Evans CJ. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 8360-9. PMID 12967998 DOI: 10.1523/Jneurosci.23-23-08360.2003  0.748
2003 Wilson SG, Bryant CD, Lariviere WR, Olsen MS, Giles BE, Chesler EJ, Mogil JS. The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice. The Journal of Pharmacology and Experimental Therapeutics. 305: 755-64. PMID 12606637 DOI: 10.1124/Jpet.102.047902  0.608
Show low-probability matches.